Glaxosmi. Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE159A01016
  • NSEID: GLAXO
  • BSEID: 500660
INR
2,593.05
13.45 (0.52%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 39.06 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryGlaxosmi. Pharma VS Pharmaceuticals & Biotechnology
 
1D
0.52%
-0.58%
1W
-2.28%
0.52%
1M
7.91%
0.41%
YTD
4.94%
-7.89%
1Y
-3.21%
-2.63%
3Y
85.42%
19.02%
5Y
57.67%
44.63%
10Y
64.79%
179.57%
  • Stock Absolute Returns
  • India SENSEXAbsolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (2.21%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.6%
2.34%
6.94%
6 Months
4.31%
2.27%
6.58%
1 Year
-3.21%
2.06%
-1.15%
2 Years
-8.1%
2.35%
-5.75%
3 Years
85.42%
7.15%
92.57%
4 Years
84.19%
9.11%
93.3%
5 Years
57.67%
12.70%
70.37%

Latest dividend: 57 per share ex-dividend date: May-29-2026

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
5.8%
3
Quartile
quartile-3
Mar-Jun
7.34%
4
Quartile
quartile-4
Dec-Mar
-7.59%
4
Quartile
quartile-4
YTD
-2.09%
2
Quartile
quartile-2
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
5.8%
4
Quartile
quartile-4
Mar-Jun
7.34%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
YTD
-2.09%
1
Quartile
quartile-1
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

Glaxosmithkline Pharmaceuticals Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
5.8%
3
Quartile
quartile-3
Mar-Jun
7.34%
2
Quartile
quartile-2
Dec-Mar
-7.59%
3
Quartile
quartile-3
YTD
-2.09%
2
Quartile
quartile-2
2025
9.72%
3
Quartile
quartile-3
2024
18.69%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s India SENSEX
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available